Recent Talks on Process Analytical Technology (PAT)
Live Webinar

Recent Talks on PAT Implementation

Live Webinar

This July 15 digital event comprises of two recent presentations, which share best practices and trends around the implementation and utilization of Process Analytical Technology (PAT).

Recent Talks on PAT Implementation
Recent Talks on PAT Implementation
Presentations
  • Multi-Scale PAT for Small Molecule Development
    Dr. Zachary Dance - Merck & Co., Inc.

  • Automation at AbbVie: The Culture and Impact of Adopting New Technology
    Westin Morrill - AbbVie

During this live stream, a technology and application expert will be online to answer your questions live.

90 Minutes
Wed Jul 15 2020 13:00 +0000 [ English ]

If you are unable attend the live event, register to receive links to the on-demand presentations.

Your Presenters

Dr. Zachary Dance – Merck
After receiving his Ph.D. in Physical Organic Chemistry from Northwestern University, Dr. Dance joined Merck’s Center for Materials Science and Engineering. Since then, he has developed expertise in solid state characterization and PAT in materials of pharmaceutical interest. Most recently, Dr. Dance has led the Merck Research Labs Small Molecule PAT team. He has experience supporting development at all scales, troubleshooting, process optimization, and experimental design related to synthetic reaction understanding and physicochemical properties of APIs and excipients, as well as contributing to multiple patent and regulatory filings.

Westin Morrill - Abbvie
Westin Morrill is a Process Chemist for AbbVie, in North Chicago, IL. He completed his undergraduate work at Portland State University under the guidance of Professor David Peyton in 2009. This lead to his work on development of anti-malarial drugs at DesignMedix, also in Portland. In 2013, he earned an industrial Master of Science in Chemistry from the University of Oregon while working at W.R. Grace developing large scale manufacturing conditions for organometallic complexes and nucleosides. In 2013, he started at the AbbVie Process Chemistry group. He has been a part of several programs, including the process development for Glecaprevir. In conjunction with Process Chemistry, he also helps lead the automation effort at AbbVie.

Thank you for visiting www.mt.com. We have tried to optimize your experience while on the site, but we noticed that you are using an older version of a web browser. We would like to let you know that some features on the site may not be available or may not work as nicely as they would on a newer browser version. If you would like to take full advantage of the site, please update your web browser to help improve your experience while browsing www.mt.com.